Kalehua Capital Management LLC
23 holdingsFiling period: 2026-03-31Current AUM: $142.0Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | XFOR | X4 Pharmaceuticals Inc | 3.72M | $15.4M | $14.8M | 10.44% | -- | 2026-03-31 |
| 2 | BOXX | Alpha Architect 1-3 Month Box ETF | 118.4K | $13.8M | $13.9M | 9.82% | -112,365 | 2026-03-31 |
| 3 | SRZN | Surrozen Inc | 385.2K | $11.2M | $8.6M | 6.02% | -- | 2026-03-31 |
| 4 | RLAY | Relay Therapeutics Inc | 901.5K | $9.0M | $17.0M | 11.95% | -- | 2026-03-31 |
| 5 | SION | Sionna Therapeutics Inc | 197.1K | $7.9M | $9.3M | 6.54% | -- | 2026-03-31 |
| 6 | MANE | Veradermics Inc | 102.9K | $6.5M | $10.8M | 7.61% | -- | 2026-03-31 |
| 7 | ORKA | Oruka Therapeutics Inc | 118.5K | $5.8M | $11.4M | 8.06% | -- | 2026-03-31 |
| 8 | — | Pharvaris NV | 198.8K | $5.6M | $5.6M | 3.95% | -- | 2026-03-31 |
| 9 | ACRS | ACLARIS THERAPEUTICS INC | 1.34M | $5.0M | $7.0M | 4.90% | -- | 2026-03-31 |
| 10 | SEPN | Septerna Inc | 194.5K | $4.7M | $6.7M | 4.72% | -- | 2026-03-31 |
| 11 | CMPS | Compass Pathways PLC | 819.7K | $4.5M | $9.3M | 6.55% | -- | 2026-03-31 |
| 12 | IKT | Inhibikase Therapeutics Inc | 2.67M | $4.5M | $5.8M | 4.10% | +922.6K | 2026-03-31 |
| 13 | LONA | LeonaBio Inc | 393.7K | $4.0M | $2.8M | 1.96% | -- | 2026-03-31 |
| 14 | DMRA | Damora Therapeutics Inc | 139.0K | $3.6M | $4.0M | 2.84% | -- | 2026-03-31 |
| 15 | — | Uniqure NV | 211.7K | $3.5M | $3.5M | 2.44% | -- | 2026-03-31 |
| 16 | MLTX | MoonLake Immunotherapeutics | 175.7K | $3.3M | $3.2M | 2.28% | -- | 2026-03-31 |
| 17 | TYRA | Tyra Biosciences Inc | 74.5K | $2.9M | $2.4M | 1.67% | -- | 2026-03-31 |
| 18 | GOSS | Gossamer Bio Inc | 7.47M | $2.5M | $1.3M | 0.89% | -- | 2026-03-31 |
| 19 | TNYA | Tenaya Therapeutics Inc | 2.00M | $1.4M | $1.5M | 1.04% | -- | 2026-03-31 |
| 20 | PEPG | PepGen Inc | 730.0K | $1.3M | $1.3M | 0.90% | -- | 2026-03-31 |
| 21 | TIL | Instil Bio Inc | 139.8K | $1.2M | $995K | 0.70% | -- | 2026-03-31 |
| 22 | KLRS | Kalaris Therapeutics Inc | 135.6K | $782K | $476K | 0.34% | -4,316 | 2026-03-31 |
| 23 | DMAC | DiaMedica Therapeutics Inc | 62.5K | $423K | $396K | 0.28% | -32,871 | 2026-03-31 |
← Scroll →